GSK PLC closed 20.84% below its 52-week high of £18.24, which the company achieved on May 16th.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

CEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over £31 billion, with specialty medicines driving performance. Core operating profit grew 13%, supporting a ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

It came as the boss of the London-listed firm cheered an ‘excellent’ performance in 2024. GSK has increased its long-term sales guidance amid hopes for a boost from new speciality medicines ...

The Department of Homeland Security is asking for the Internal Revenue Service to help crack down on immigration, according ...

Whatever its merits, GSK decided it was wiser to pay up and move on. There’ll no doubt be more. Investors also worry about Donald Trump’s new health secretary, vaccine sceptic Robert F Kennedy ...

British pharmaceutical giant GSK raised its long-term sales guidance on Wednesday as it posted a rise in full-year core ...

British pharmaceutical giant GSK raised its long-term sales guidance on Wednesday as it posted a rise in full-year core operating profit and forecast sales growth of up to 5% in 2025. GSK's core ...

When asked about the change in administration in the U.S., GSK CEO Emma Walmsley said, "Let's wait and see.” “There is categorically no better return on healthcare budgets and no better ...

Eli Lilly made a $2.5 billion deal for a breast cancer drug; GSK reached a $1 billion-plus deal for IDRx. The announcements suggest a potential rebound in M&A deals in the healthcare sector for 2025.